GSK s vaccine for respiratory syncytial virus won the support of a key panel of U.S. regulatory advisers for use in people 60 and older, as the drugmaker races against Pfizer to bring to market the first vaccine for RSV.
CDC signs off on updated Covid-19 boosters localnews8.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from localnews8.com Daily Mail and Mail on Sunday newspapers.
CDC vaccine advisers vote to recommend updated Covid-19 boosters wishtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wishtv.com Daily Mail and Mail on Sunday newspapers.